Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 91
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01407679 | Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythematosus | ||
| NCT02957929 | Safety, Pharmacokinetics, Bioavailability, Food Effect, Drug-Drug Interaction Study of APX001 Administered Orally | ||
| NCT05582187 | A Clinical Trial of the Study Medicine (Called Fosmanogepix) in Participants With Varying Degrees of Hepatic Function. | ||
| NCT01582425 | Drug Interaction Study of Isavuconazole and Methadone | ||
| NCT01030731 | Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease | ||
| NCT03604705 | An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With Candidemia | ||
| NCT03138733 | Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia | ||
| NCT00770978 | Open Label Study of Ceftobiprole to Evaluate Pharmacokinetics in Adults Hospitalized in the ICU | ||
| NCT04166669 | A Drug-Drug Interaction Study of CYP3A4 Inhibition and Pan-CYP Induction on APX001 | ||
| NCT01660477 | Drug-drug Interaction Study Between Lopinavir/Ritonavir and Isavuconazole | ||
| NCT01752920 | Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations | ||
| NCT02527681 | Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics | ||
| NCT03250299 | Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma | ||
| NCT05856227 | Late-onset Sepsis in Term and Pre-term Neonates and Infants up to 3 Months of Age | ||
| NCT04243863 | VNRX-7145 SAD/MAD Safety and PK in Healthy Adult Volunteers | ||
| NCT00413439 | Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing Chemotherapy | ||
| NCT04604132 | Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma | ||
| NCT01813461 | Study to Evaluate the Pharmacokinetics of 14C-labeled Isavuconazole Following a Single Oral Dose of 14C-labeled Prodrug Isavuconazonium Sulfate (BAL8557) in Healthy Male Subjects | ||
| NCT00771719 | Open Label Pharmacokinetic in Adult Patients With Ventilator-Associated Pneumonia | ||
| NCT01651325 | Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Dextromethorphan in Healthy Adult Subjects | ||
| NCT00229008 | Ceftobiprole in Hospital Acquired Pneumonia | ||
| NCT02956499 | Study to Assess Safety, Tolerability and Pharmacokinetics of APX001 Administered by Intravenous Infusion to Healthy Subjects | ||
| NCT00210899 | Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections | ||
| NCT00529282 | A Study of Ceftobiprole in Patients With Fever and Neutropenia. | ||
| NCT01635972 | Drug Interaction Study of Multiple Doses of Isavuconazole and a Single Dose of Bupropion | ||
| NCT00634049 | Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi | ||
| NCT04148287 | An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida Auris | ||
| NCT00412893 | Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis | ||
| NCT04087876 | Expanded Access Use of Derazantinib for Advanced Intrahepatic Cholangiocarcinoma (iCCA) With FGFR Genomic Alterations | ||
| NCT05488678 | Ceftibuten/VNRX-7145 in Participants With Varying Degrees of Renal Function | ||
| NCT02059590 | A Study to Evaluate the Pharmacokinetics of BAL8728 After a Single Dose of Pyridinylmethyl-14C-Labeled Isavuconazonium Sulfate in Healthy Male Subjects | ||
| NCT01582412 | Drug Interaction Study of Isavuconazole and Digoxin | ||
| NCT01884636 | A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Methotrexate | ||
| NCT01597986 | Drug Interaction Study of Isavuconazole and Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone | ||
| NCT06808646 | A Study to Assess the Effect of Ceftobiprole on the PK of Pitavastatin and on Plasma Levels of Coproporphyrin | ||
| NCT02895360 | Phase 1/2a Study of BAL101553 as 48-hour Infusions in Patients With Advanced Solid Tumors or Recurrent Glioblastoma | ||
| NCT04240886 | Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare Molds | ||
| NCT03230318 | Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma | ||
| NCT01731353 | FungiScope - A Global Emerging Fungal Infection Registry | ||
| NCT06433128 | Expanded Access to Fosmanogepix for Patients With Serious or Life-threatening Invasive Fungal Infections | ||
| NCT01657825 | Drug Interaction Study of Isavuconazole and Warfarin in Healthy Male Subjects | ||
| NCT00771524 | Pharmacokinetic Study of the Penetration of Ceftobiprole in the Bone | ||
| NCT03439124 | Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia | ||
| NCT00817063 | Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema | ||
| NCT01026558 | A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients | ||
| NCT03333005 | Safety and Pharmacokinetics of Intravenous and Oral APX001 in Patients With Acute Myeloid Leukemia (AML) and Neutropenia | ||
| NCT00326287 | Ceftobiprole in the Treatment of Patients With Community-Acquired Pneumonia | ||
| NCT00965042 | Effect of Ceftobiprole on Human Intestinal Microflora | ||
| NCT06665555 | Plasma and Intrapulmonary Pharmacokinetics of Ceftibuten and Ledaborbactam in Healthy Adults (18-55 Years) | ||
| NCT05527834 | Food Effect on Ceftibuten/VNRX-7145 in Healthy Participants |
